| Bioactivity | DP50 is a bifunctional compound that contains an opioid receptor (MOP) agonist and a neuropeptide FF receptor (NPFFR) antagonist. DP50 can be used in analgesia-related research[1]. |
| Sequence | {Dmt}-{NMe-d-Ala}-{1Ana}-{βAla}-{Bpa}-Phe-NH2 |
| Shortening | {Dmt}-{NMe-d-Ala}-{1Ana}-{βAla}-{Bpa}-P-NH2 |
| Formula | C58H72N8O7 |
| Molar Mass | 993.24 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. De Neve J,et al. Multitarget μ-Opioid Receptor Agonists─Neuropeptide FF Receptor Antagonists Induce Potent Antinociception with Reduced Adverse Side Effects. J Med Chem. 2024 May 9;67(9):7603-7619. |